IPP Bureau
Corona Remedies acquires 7 brands from Bayer's pharma division in India
By IPP Bureau - July 17, 2025
This marks the fourth acquisition by Corona Remedies from multinational corporations
Thermo Fisher Scientific to acquire Sanofi’s steriles manufacturing site in Ridgefield, New Jersey
By IPP Bureau - July 17, 2025
Enables additional US manufacturing capacity to serve increased demand for pharma/biotech customers
Cipla Health launches Astaberry's campaign 'Get the Rich Look'
By IPP Bureau - July 17, 2025
The campaign celebrates radiant, healthy skin that shines naturally, empowering women to step forward with confidence in every walk of life.
Briefs: Godavari Biorefineries and Anuh Pharma
By IPP Bureau - July 16, 2025
Godavari Biorefineries receives patent from CNIPA
Waters, BD biosciences unit agree to $17.5 billion merger
By IPP Bureau - July 16, 2025
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
Milestone Pharmaceuticals announces FDA acceptance of response to Cardamyst nasal spray CRL
By IPP Bureau - July 15, 2025
Milestone also announced the extension of its $75 million Royalty Purchase Agreement with RTW Investments
FDA approves Bayer’s Finerenone for new indication in patients with HF and LVEF of ?40%
By IPP Bureau - July 15, 2025
Finerenone significantly reduced the combined risk of cardiovascular death and total (first and recurrent) heart failure events,
India launches nutraceutical trade expo ‘Bharat Nutraverse’
By IPP Bureau - July 15, 2025
India’s nutraceutical industry is expected to reach over US$ 22 billion in 2025
Lilly partners with API to launch ‘Obesity Gurukul’ in India
By IPP Bureau - July 15, 2025
The program will offer a structured and immersive learning experience for over 20,000 healthcare professionals across more than 10 cities
PharmaJet inks MoU with Egypt’s UPA and EVA Pharma to offer needle-free delivery for routine immunization
By IPP Bureau - July 15, 2025
The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
WHO, ITU, and WIPO release new report on AI use in traditional medicine
By IPP Bureau - July 15, 2025
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
Valneva lifts EMA’s temporary restriction on use of chikungunya vaccine IXCHIQ in elderly
By IPP Bureau - July 15, 2025
The agency concluded that for people of all ages, IXCHI should be administered when there is a significant risk of chikungunya infection
Capricor receives FDA’s CRL for Deramiocel BLA for duchenne muscular dystrophy
By IPP Bureau - July 15, 2025
Capricor’s BLA for Deramiocel received Priority Review in March 2025
Zydus receives final approval from USFDA for Celecoxib Capsules
By IPP Bureau - July 15, 2025
Celecoxib is a nonsteroidal anti-inflammatory drug
